NEW YORK (GenomeWeb) – The National Institutes of Health will award up to $5 million next fiscal year to fund one or two research teams that will use a range of biomarker typesto identify the progression of Alzheimer's disease in adults who have Down syndrome.

Adults with Down syndrome are at "extremely high risk" of developing AD, NIH said in a funding announcement on Friday. These projects will seek to characterize the longitudinal trajectory of AD-related genetic, biochemical, imaging, clinical, and cognitive biomarkers in adults with Down syndrome.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.